Stock Scorecard



Stock Summary for CureVac N.V. (CVAC) - $5.45 as of 7/4/2025 12:53:24 AM EST

Total Score

17 out of 30

Safety Score

39 out of 100

Currently on the following lists
None
Tim's Recommendation
Possible Buy

Growth List Algorithm Criteria for CVAC

Positive Quarterly and Annual earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the Annual earnings growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for CVAC

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for CVAC

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for CVAC

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for CVAC (39 out of 100)

Stock Price Rating (Max of 10) 4
Historical Stock Price Rating (Max of 10) 8
Stock Price Trend (Max of 10) 1
Book Value (Max of 10) 3
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 3
Analyst Strong Buy Ratings (Max of 5) 3
Dividend Yield Percentage (Max of 10) 0
Operating Margin (Max of 10) 0
Trading Volume (Max of 10) 8
Price to Earnings (Max of 10) 9
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Latest News for for CVAC

CureVac Soars 41% in a Month on a $1.25B Buyout Offer From BioNTech 6/20/2025 3:51:00 PM
$HAREHOLDER ALERT: Class Action Attorney Juan Monteverde Investigates the Merger of CureVac N.V. ( NASDAQ: CVAC ) 6/20/2025 1:24:00 PM
BioNTech Announces Strategic Transaction to Acquire CureVac in Public Exchange Offer 6/12/2025 10:45:00 AM
Invivyd, Inc. ( IVVD ) Reports Q1 Loss, Lags Revenue Estimates 5/15/2025 12:15:00 PM
Kamada ( KMDA ) Q1 Earnings Match Estimates 5/14/2025 12:10:00 PM
Ovid Therapeutics ( OVID ) Reports Q1 Loss, Tops Revenue Estimates 5/13/2025 1:15:00 PM
RNA Therapeutics Market is expected to generate a revenue of USD 22.37 Billion by 2032, Globally, at 9.4% CAGR: Verified Market Research® 3/17/2025 2:00:00 PM
Is the Options Market Predicting a Spike in CureVac ( CVAC ) Stock? 11/20/2024 4:18:00 PM
CorMedix ( CRMD ) Reports Q2 Loss, Tops Revenue Estimates 8/14/2024 12:45:00 PM
Adherex Technologies Inc. ( FENC ) Reports Q2 Loss, Lags Revenue Estimates 8/13/2024 11:25:00 AM

Financial Details for CVAC

Company Overview

Ticker CVAC
Company Name CureVac N.V.
Country USA
Description CureVac NV, a clinical-stage biopharmaceutical company, is focused on developing various transformative drugs based on messenger ribonucleic acid (mRNA). The company is headquartered in Tbingen, Germany.
Sector Name LIFE SCIENCES
Industry Name PHARMACEUTICAL PREPARATIONS
Most Recent Quarter 3/31/2025
Next Earnings Date N/A

Stock Price History

Last Day Price 5.45
Price 4 Years Ago 34.31
Last Day Price Updated 7/4/2025 12:53:24 AM EST
Last Day Volume 751,012
Average Daily Volume 1,749,049
52-Week High 5.72
52-Week Low 2.37
Last Price to 52 Week Low 129.96%

Valuation Measures

Trailing PE 5.76
Industry PE 21.93
Sector PE 40.90
5-Year Average PE -21.35
Free Cash Flow Ratio 2.79
Industry Free Cash Flow Ratio 17.71
Sector Free Cash Flow Ratio 32.91
Current Ratio Most Recent Quarter 7.65
Total Cash Per Share 1.95
Book Value Per Share Most Recent Quarter 2.87
Price to Book Ratio 1.61
Industry Price to Book Ratio 34.53
Sector Price to Book Ratio 30.76
Price to Sales Ratio Twelve Trailing Months 2.33
Industry Price to Sales Ratio Twelve Trailing Months 121.97
Sector Price to Sales Ratio Twelve Trailing Months 35.60
Analyst Buy Ratings 2
Analyst Strong Buy Ratings 1

Share Statistics

Total Shares Outstanding 225,159,000
Market Capitalization 1,227,116,550
Institutional Ownership 4.70%

Dividends

Ex-Dividend Date N/A
Previous Dividend Amount 0.0000
Current Dividend Amount 0.0000
Total Years Dividend Increasing N/A
Trailing Annual Dividend Rate 0.00
Trailing Annual Dividend Yield 0.00%
Forward Annual Dividend Rate 0.00
Forward Annual Dividend Yield 0.00%
5-Year Dividend Payments Count 0
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 0.00%
3-Year Dividend Growth Rate Percentage 0.00%
5-Year Dividend Growth Rate Percentage 0.00%
All-Time Dividend Growth Rate Percentage 0.00%
Dividend Payout Ratio N/A

Income Statement

Quarterly Earnings Growth YOY 0.00%
Annual Earnings Growth 162.34%
Reported EPS 12 Trailing Months 0.94
Reported EPS Past Year -0.16
Reported EPS Prior Year 0.62
Net Income Twelve Trailing Months 180,655,000
Net Income Past Year 162,186,000
Net Income Prior Year -260,167,000
Quarterly Revenue Growth YOY -92.80%
5-Year Revenue Growth 98.39%
Operating Margin Twelve Trailing Months -6,128.00%

Balance Sheet

Total Cash Most Recent Quarter 438,331,000
Total Cash Past Year 481,748,000
Total Cash Prior Year 402,452,000
Net Cash Position Most Recent Quarter 410,788,000
Net Cash Position Past Year 481,748,000
Long Term Debt Past Year 0
Long Term Debt Prior Year 65,018,000
Total Debt Most Recent Quarter 27,543,000
Equity to Debt Ratio Past Year 1.00
Equity to Debt Ratio Most Recent Quarter 0.96
Total Stockholder Equity Past Year 696,608,000
Total Stockholder Equity Prior Year 516,941,000
Total Stockholder Equity Most Recent Quarter 646,689,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months 143,168,000
Free Cash Flow Per Share Twelve Trailing Months 0.64
Free Cash Flow Past Year 83,407,000
Free Cash Flow Prior Year -323,087,000

Options

Put/Call Ratio 0.33
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD 0.31
MACD Signal 0.36
20-Day Bollinger Lower Band 1.89
20-Day Bollinger Middle Band 3.80
20-Day Bollinger Upper Band 5.71
Beta 2.49
RSI 67.98
50-Day SMA 3.44
150-Day SMA 5.63
200-Day SMA 10.97

System

Modified 7/2/2025 9:43:06 PM EST